Sermorelin

Sermorelin
Systematic (IUPAC) name
L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide
Clinical data
Trade names Geref
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • US: C (Risk not ruled out)
Legal status
  • US: Discontinued
Routes of
administration
Injection
Identifiers
CAS Number 86168-78-7 YesY
ATC code H01AC04 V04CD03
PubChem CID 16132413
DrugBank DB00010 N
ChemSpider 17289071 N
UNII 89243S03TE N
KEGG D08509 YesY
ChEMBL CHEMBL1201490 N
Synonyms GRF 1–29
Chemical data
Formula C149H246N44O42S
Molar mass 3357.882 g/mol
 NYesY (what is this?)  (verify)

Sermorelin (INN) (trade name is Geref), also known as GHRH (1-29), is a growth hormone-releasing hormone (GHRH) analogue used as a diagnostic agent. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, and is thought to be the shortest fully functional fragment of GHRH.[1] It is used as a diagnostic agent to assess growth hormone (GH) secretion.[2] It is also used as doping agent in sports due to its correlation with increased growth of muscular and skeletal tissue. Sermorelin use is also hypothesized to improve deep rapid eye movement sleep.

See also

References

  1. Prakash A, Goa KL (August 1999). "Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency". BioDrugs 12 (2): 139–57. doi:10.2165/00063030-199912020-00007. PMID 18031173.
  2. Pharmacology (Rang, Dale, Ritter & Moore, ISBN 0-443-07145-4, 5th ed., Churchill Livingstone 2003).


This article is issued from Wikipedia - version of the Sunday, February 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.